What people are saying about vLife™
Biopharma and Medtech companies require sensitive EMR data for pre-clinical research, clinical trials, biomarker analysis, pre-and post-market analysis to name a few use cases that warrant the need for prediction models trained on large datasets of practically unattainable data. To close these gaps, organizations and researchers require access to large repositories of high-quality health datasets for a range of secondary uses that have no clinical or medical implications, including software development, testing, and clinical training. Synthetic data will accelerate the pace of development for AI. vLife is our platform for synthetic and anonymous data for our customer who wish to find creative paths towards technology-based innovation to just stay relevant, let alone truly disrupt.
– Executive Vice President, Virtusa, Jim Francis
Partnering with Virtusa will help the IBRI to achieve its objective of enabling regional, large life sciences companies to access data and technologies from a variety of organizations. Through the vLife™ open innovation platform, we’re exploring and enabling life sciences firms to accelerate progress towards finding next-level treatments by providing seamless access to focused, timeline-driven collaboration with universities, government entities, healthcare providers, and other research institutes and organizations.”
– Ph.D, Research Fellow and Vice President of Digital Technology, and Director of the Applied Data Sciences Center for the IBRI, Daniel H. Robertson
Life science companies must address how to seize the upside of disruption in today’s transformation age. Future value in life science is driven by innovation that focuses on outcomes with a high degree of personalization and is fueled by unlocking the power of synthetic data.
– Senior Vice President, Healthcare and Life Sciences, Virtusa, Anthony Lange
By working together, we believe we can address the increasing customer demand for cloud transformation expertise in industry verticals such as financial services, healthcare, life sciences and more to create significant value for all parties in the process, Virtusa is a valued member of the AWS Partner Network (APN) and the SCA deepens the relationship between our two organizations to provide more value to our customers.
– Global Vice President of Channels and Alliances, Amazon Web Services, Inc., Terry Wise
Data drives solutions to the most difficult healthcare challenges of today and tomorrow. Researchers need data that is accessible, complete, and accurate. We need to look at synthetic data differently by applying AI and Big Data technologies to extend and enhance real-world evidence. We’re excited to see how Proxi will accelerate healthcare analysis and outcomes
– Principal Engineer of Data Analytics at Fuse, Jeff Graham
As a firm, our roots and ethos are deep in software engineering. Our program with IBRI is only one example of how we are working with clients to solve complex industry issues. We have also solved similar issues for companies in other industries, such as banking, insurance, media, communication, info services, healthcare, and life sciences.
– President at Virtusa, Samir Dhir